Regeneron Pharmaceuticals Inc. insider trades

as of filings through Nov 6, 2026

Hide plannedHide planned trades

FiledStockInsiderSideValueSharesAvg priceTraded

Filed Nov 6, 4:01 PM (the Form 4 at the SEC), traded Nov 4REGNSoldJason Pitofsky · SVP ControllerSell$3.8M4,062$942.19Nov 4
Filed Nov 5, 4:05 PM (the Form 4 at the SEC), traded Nov 3REGNSoldHuda Y. Zoghbi · DirectorSell$7.2M7,439$970.46Nov 3
Filed Nov 4, 4:11 PM (the Form 4 at the SEC), traded Nov 2REGNSoldGeorge L. Sing · DirectorSell$20.4M21K$964.38Nov 2
Filed Nov 4, 4:09 PM (the Form 4 at the SEC), traded Nov 2REGNSoldChristine A. Poon · DirectorSell$7.6M7,830$969.09Nov 2
Filed Nov 4, 4:04 PM (the Form 4 at the SEC), traded Nov 2REGNSoldJoseph J. Larosa · EVP General Counsel and SecretSell$4.3M4,466$965.49Nov 2
Filed Nov 3, 4:22 PM (the Form 4 at the SEC), traded Oct 30 · 4d late to fileREGNSoldKathryn Guarini · DirectorPlanSell$360K400$900.00Oct 30
Filed Nov 3, 4:05 PM (the Form 4 at the SEC), traded Oct 30 · 4d late to fileREGNSoldMichael S. Brown · DirectorPlanSell$1.7M1,929$875.00Oct 30
Filed Nov 3, 4:02 PM (the Form 4 at the SEC), traded Oct 30 · 4d late to fileREGNSoldMarion McCourt · EVP CommercialPlanSell$984K1,132$869.43Oct 30
Filed Oct 15, 4:02 PM (the Form 4 at the SEC), traded Oct 14REGNSoldAndrew J. Murphy · Co-Chief Scientific OfficerPlanSell$3.2M4,147$772.70Oct 14

More on REGN